Form 4: Cyanotech Director Michael Davis Increases Stake in Company

Sentiment:

SEC Form 4 Filing


Director Michael Davis increased his holdings in Cyanotech through purchases made under a pre-arranged trading plan.

Summary

  • On August 27 and 28, 2024, Michael Davis, a director and 10% owner of Cyanotech Corporation, acquired 5,000 shares each day at prices of $0.80 and $0.79 per share, respectively.
  • These purchases were made under a pre-arranged trading plan (Rule 10b5-1(c)) adopted on March 6, 2024.
  • Following these transactions, Davis's indirect beneficial ownership through his revocable trust increased to 1,246,736 shares.
  • Davis also has indirect ownership through his spouse (31,250 shares), as co-trustee for the Nyracai Davis Irr. Trust and the Nettizanne J. Davis Irr. Trust (150,000 shares), as trustee for the Nettizanne Johnstone Davis GST Exempt Trust (58,000 shares), and as trustee for the Nyracai Johnstone Davis GST Exempt Trust (58,789 shares).
  • He also directly owns 12,119 shares.

Sentiment

Score: 6

Explanation: Insider buying is generally viewed positively, but the purchases were relatively small and made under a pre-existing plan, limiting the impact on sentiment.

Positives

  • A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored as an indicator of management's sentiment about the company's prospects. It's a common practice for executives and directors to have pre-arranged trading plans to avoid accusations of trading on inside information.

Stakeholder Impact

  • The increased stake by a director could positively influence shareholder confidence.

Key Dates

DateDescription
03-06-2024Adoption date of the referenced 10b5-1(c) plan
08/27/2024Michael Davis purchased 5,000 shares of Cyanotech at $0.80 per share.
08/28/2024Michael Davis purchased 5,000 shares of Cyanotech at $0.79 per share.
08/29/2024Date of signature on the Form 4 filing.

Keywords

Cyanotech, Michael Davis, insider trading, Form 4, beneficial ownership, stock purchase, Rule 10b5-1, director, shareholder

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.